Palvella Therapeutics, Inc.
PVLA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583648
In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 196 institutions reported holding it in 13F filings for Q2 2026, worth $2.15B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Palvella Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +20 vs. Q1 2024
- Shares held
- 362.3K
- +362.3K vs. Q1 2024
- Total value
- $3.57M
- +$3.57M vs. Q1 2024
- New holders
- 20
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PVLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $2.15B |
| Q1 2026 | 180 | $1.64B |
| Q4 2025 | 140 | $1.02B |
| Q3 2025 | 100 | $534.5M |
| Q2 2025 | 67 | $133.2M |
| Q1 2025 | 41 | $143.4M |
| Q4 2024 | 33 | $48.4M |
| Q3 2024 | 25 | $10.1M |
| Q2 2024 | 20 | $3.57M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Palvella Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 257,626 | $2.55M | 0.07% | +257,626 | New |
| Lynx1 Capital Management LP | 43,499 | $426.8K | 0.15% | +43,499 | New |
| BlackRock Inc. | 12,975 | $127.3K | 0.00% | +12,975 | New |
| Renaissance Technologies LLC | 11,471 | $112.5K | 0.00% | +11,471 | New |
| Vanguard Group Inc | 11,342 | $111.3K | 0.00% | +11,342 | New |
| Acadian Asset Management LLC | 10,827 | $106.0K | 0.00% | +10,827 | New |
| Geode Capital Management, LLC | 10,623 | $105.0K | 0.00% | +10,623 | New |
| UBS Group AG | 1,726 | $16.9K | 0.00% | +1,726 | New |
| Citigroup Inc | 1,108 | $10.9K | 0.00% | +1,108 | New |
| Tower Research Capital LLC (TRC) | 334 | $3.28K | 0.00% | +334 | New |
| Group One Trading, L.P. | 323 | $3.19K | 0.00% | +323 | New |
| US Bancorp | 158 | $1.55K | 0.00% | +158 | New |
| Morgan Stanley | 82 | $805 | 0.00% | +82 | New |
| Barclays PLC | 63 | $618 | 0.00% | +63 | New |
| Wells Fargo & Company | 60 | $589 | 0.00% | +60 | New |
| JPMorgan Chase & Co | 27 | $267 | 0.00% | +27 | New |
| Bank of America Corp | 13 | $128 | 0.00% | +13 | New |
| Advisor Group Holdings, Inc. | 7 | $69 | 0.00% | +7 | New |
| Allworth Financial LP | 5 | $37 | 0.00% | +5 | New |
| Royal Bank of Canada | 4 | $0 | 0.00% | +4 | New |